Remove state filters
Global Menu
Main Menu

Latest News

News update
News update

Breaking News: NDIS Provider and Worker Registration Taskforce provides update

Taskforce says there is more work to do before they take recommendations to government.
News update
News update

NDS analyses the federal budget for opportunities and challenges for NDIS reform

The federal budget, tabled just over a week ago, promised improvements in the NDIS while moderating scheme growth — we break it down.

New standard for psychotropic medicines has person-centred approach

A close up of a person holding a pill pack with different coloured pills


The Australian Commission on Safety and Quality in Health Care (ACSQHC) has released the first national standard for the use of psychotropic medicines in the clinical care of people with cognitive disability or impairment. It outlines clear steps for clinicians, service providers and consumers.  

Both the Aged Care Royal Commission and the Disability Royal Commission found that psychotropic medicines were being misused and overused in clinical care, particularly in older people with cognitive disability or impairment.  

Since March 2022, ACSQHC and the two royal commissions have worked together to find ways to reduce the use of psychotropic medicines, especially to control the behaviour of people with cognitive disability or impairment.   

A topic working group and the aged care and disability communities were consulted last year, and the new standard has been endorsed by 25 professional and consumer organisations.   

The person-centred approach in the standard takes a significant step in ensuring safer, more effective treatments that uphold the rights and dignity of older people and people with disability.  

Contact information
Pip Robertson, Project Lead - Quality & Safeguarding Health, 03 8341 4321, submit enquiry/feedback